Home » ARTICLE: PEDIATRICS » Adalimumab vs Infliximab in Luminal Pediatric Crohn's Disease: Comparable Outcomes in a Prospective Multicenter Cohort Study
Adalimumab vs Infliximab in Luminal Pediatric Crohn's Disease: Comparable Outcomes in a Prospective Multicenter Cohort Study
reviewer4you.com
30 March 2024
0 Views
0
SaveSavedRemoved 0